No relief from bloated Swiss drug prices
The price difference for medicines between Switzerland and other countries has further increased. In Switzerland, patent-protected medicines cost on average 8.9% more than in other European countries. A year ago, the price difference was 5.4%.
People abroad now pay 14.3% less for off-patent original preparations. A year ago, the price difference was only 10.8%, as the health insurance association Santésuisse and the association of research-based pharmaceutical companies Interpharma announced on Friday.
As has been the case for years, the price differences are particularly marked for generics and biosimilars, they said. According to the data, generics are 45.3% cheaper abroad, while biosimilars cost 29.9% less. The foreign price comparison compared current factory prices of medicines with those in other European countries in the period from January to April 2024.
+ Read more: Drug pricing: Swiss expert calls for more transparency
Immediate measures expected
Santésuisse Director Verena Nold pointed out that people who buy medicines in Switzerland continue to pay more than abroad, and that price differences have even increased. The association therefore expects the federal government to take immediate action, particularly regarding generics, to bring excessive prices down to the European level. Overall, more than CHF1.3 billion ($1.4 billion) could be saved annually on medicines without any loss of quality.
Interpharma Managing Director René Buholzer stated in the press release that the prices of patent-protected medicines will be brought to the European level. At constant exchange rates, the price difference to other countries would only be two percentage points. In addition, drug prices are to fall steadily. He emphasised that a one-sided focus on costs by politicians is increasingly jeopardising patients’ access to innovative medicines.
Adapted from German by DeepL/kc
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.